Precision Medicine for Prostate Cancer: Treatment News Announced at ASCO 2018

Published on

Topics include: Treatment

What can genetic testing reveal about your cancer? What tests are recommended for prostate cancer patients? On location at the 2018 American Society of Clinical Oncology (ASCO) meeting in Chicago, noted expert Dr. Heather Cheng, from Seattle Cancer Care Alliance, discusses what mutations indicate about risk and treatment strategy, tools available to match therapies to a patient’s genetic profile, and gives updates on other emerging approaches. Dr. Cheng also shares clinical results from the GENTLeMEN study, also known as a trial evaluating genetic testing for men with metastatic prostate cancer, and the potential link between breast and prostate cancer mutations. Watch now to find out the latest prostate cancer treatment research. 

Please remember the opinions expressed on Patient Power are not necessarily the views of our sponsors, contributors, partners or Patient Power. Our discussions are not a substitute for seeking medical advice or care from your own doctor. That’s how you’ll get care that’s most appropriate for you.

View more programs featuring and

Related Programs

When Do Emerging Prostate Cancer Therapies Become Standard of Care?

Prostate cancer experts Dr. Celestia Higano and Dr. Tomasz Beer share how patients can connect with the latest research developments and emerging therapies, and when to expect the standard of care to change.


ASCO 2017: Prostate Cancer Expert Roundtable Discussion

A panel of advanced prostate cancer experts discusses news from the 2017 American Society of Clinical Oncology (ASCO) meeting.


Personalizing Advanced Prostate Cancer Treatment

Dr. Emmanuel Antonarakis explores the use of a blood-based biomarker to help select patients for chemotherapy.


Join Our Community Register for Events Read Our Latest Blog

Page last updated on June 12, 2018